New radiation method may make stem cell transplants safer for older leukemia patients
NCT ID NCT07582172
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a targeted radiation technique (TMLI) combined with two chemotherapy drugs before a stem cell transplant in people aged 50 and older with acute myeloid leukemia or myelodysplastic syndrome that has not responded to treatment or has returned. The goal is to see if this approach can reduce side effects and improve outcomes compared to standard full-body radiation. About 35 participants will receive the treatment and be followed for leukemia-free survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA WITH COMPLEX KARYOTYPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells stop blood cancer relapse?
- Can a modified enzyme starve Hard-to-Treat blood cancers?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can donor immune cells tame stem cell transplant risks?
- Can a poison become a cure? arsenic trioxide put to the test in blood cancer transplant
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?